treatment pathways adherence rate
Participating oncologists in the Highmark Cancer Collaborative used the platform's recommended treatment pathways 83 percent of the time over the program's first seven quarters, beating its 80 percent target
Target goal
Actual rate
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
60%
70%
80%
100%
90%